MarkBoguniewiczMD

PubMed

• Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis.
  Eichenfield, L., Silverberg, J., Hebert, A., Boguniewicz, M.> ;The Journal of Dermatological Treatment. 2024 Dec 1
• 1 citations
  Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on P...
  Martin, S., Martin, S., Martin, S., Martin, S., Martin, S., Martin, S., , Derek K Chu, Lynda Schneider, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, ...> ;Annals of Allergy, Asthma & Immunology. 2024 Mar 1
• Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review.
  Jonathan I Silverberg, Mark Boguniewicz, Francisco J Quintana, Rachael A Clark, Lara Gross, Ikuo Hirano, Anna M Tallman, Philip M Brown, Doral Fredericks, David S Rube...> ;The Journal of Allergy and Clinical Immunology. 2023 Dec 27
• 7 citations
  Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
  Martin, S., Martin, S., Martin, S., Alexandro W L Chu, Melanie M Wong, Daniel G Rayner, Gordon H Guyatt, Juan Pablo Díaz Martinez, Renata Ceccacci, Irene X Zhao, Eric ...> ;The Journal of Allergy and Clinical Immunology. 2023 Dec 1
• 2 citations
  Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
  Martin, S., Martin, S., Martin, S., Derek K Chu, Alexandro W L Chu, Daniel G Rayner, Gordon H Guyatt, Juan José Yepes-Nuñez, Luis Gomez-Escobar, Lucia C Pérez-Herrera,...> ;The Journal of Allergy and Clinical Immunology. 2023 Dec 1
• 4 citations
  The role of Janus kinase signaling in the pathology of atopic dermatitis.
  Emma Guttman-Yassky, Alan D Irvine, Patrick M Brunner, Brian S Kim, Mark Boguniewicz, Julie Parmentier, Andrew M Platt, Kenji Kabashima> ;The Journal of Allergy and Clinical Immunology. 2023 Dec 1
• 1 citations
  Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibition.
  Eric L Simpson, Emma Guttman-Yassky, Lawrence F Eichenfield, Mark Boguniewicz, Thomas Bieber, Shannon Schneider, Adriana Guana, Jonathan I Silverberg> ;Allergy. 2023 Nov 1
• 9 citations
  Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment.
  Eric L Simpson, Patrick M Schlievert, Takeshi Yoshida, Stephanie Lussier, Mark Boguniewicz, Tissa Hata, Zelma Fuxench, Anna De Benedetto, Peck Y Ong, Justin Ko, Agusti...> ;The Journal of Allergy and Clinical Immunology. 2023 Nov 1
• 3 citations
  Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) Registry.
  Eric L Simpson, Anna De Benedetto, Mark Boguniewicz, Peck Y Ong, Stephanie Lussier, Miguel Villarreal, Lynda C Schneider, Amy S Paller, Emma Guttman-Yassky, Jon M Hani...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 Aug 1
• 5 citations
  Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin.
  Donald Y M Leung, Robert Bissonnette, Simion Kreimer, Evgeny Berdyshev, Shantanu Bafna, Taras Lyubchenko, Brittany N Richers, Shannon Garcia, Marco Ramirez-Gama, Clift...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 May 1
• 6 citations
  Atopic Dermatitis Yardstick update.
  Mark Boguniewicz, Luz Fonacier, Emma Guttman-Yassky, Peck Y Ong, Jonathan I Silverberg> ;Annals of Allergy, Asthma & Immunology. 2023 Jun 1
• 19 citations
  Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
  Martin, S., Juan José Yepes-Nuñez, Gordon H Guyatt, Luis Guillermo Gómez-Escobar, Lucia C Pérez-Herrera, Alexandro W L Chu, Renata Ceccaci, Ana Sofía Acosta-Madiedo, A...> ;The Journal of Allergy and Clinical Immunology. 2023 Jan 1
• 3 citations
  Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical ...
  Jonathan I Silverberg, Mark Boguniewicz, Jon Hanifin, Kim A Papp, Haixin Zhang, Ana B Rossi, Noah A Levit> ;Dermatology and Therapy. 2022 Dec 1
• 2 citations
  Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes.
  Eric Simpson, April Armstrong, Mark Boguniewicz, Zelma C Chiesa Fuxench, Meghan Feely, Evangeline Pierce, Luna Sun, Yun-Fei Chen, Robinette Angle, Jonathan I Silverberg> ;Dermatologic Therapy. 2022 Dec 1
• 5 citations
  Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis.
  Kristian Reich, Peter A Lio, Robert Bissonnette, Andrew F Alexis, Mark G Lebwohl, Andrew E Pink, Kenji Kabashima, Mark Boguniewicz, Roman J Nowicki, Hernan Valdez, Fan...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2022 Dec 1
• 2 citations
  Abrocitinib monotherapy in Investigator's Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life.
  Andrew Blauvelt, Mark Boguniewicz, Patrick M Brunner, Paula C Luna, Pinaki Biswas, Marco DiBonaventura, Saleem A Farooqui, Ricardo Rojo, Michael C Cameron> ;The Journal of Dermatological Treatment. 2022 Aug 1
• 11 citations
  Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis.
  Paul Oykhman, Jared Dookie, Husam Al-Rammahy, Anna de Benedetto, Rachel N Asiniwasis, Jennifer LeBovidge, Julie Wang, Peck Y Ong, Peter Lio, Alvin Gutierrez, Korey Cap...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2022 Oct 1
• 23 citations
  Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis.
  Evgeny Berdyshev, Elena Goleva, Robert Bissonnette, Irina Bronova, Anna Sofia Bronoff, Brittany N Richers, Shannon Garcia, Marco Ramirez-Gama, Patricia Taylor, Amy Pra...> ;Allergy. 2022 Nov 1
• 14 citations
  Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE.
  Layla Bakaa, Jeffrey M Pernica, Rachel J Couban, Kelly Jo Tackett, Craig N Burkhart, Liz Leins, Joanne Smart, Maria Teresa Garcia-Romero, Itzel Guadalupe Elizalde-Jimé...> ;Annals of Allergy, Asthma & Immunology. 2022 Jun 1
• 5 citations
  Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16.
  Jonathan I. Silverberg, Mark Boguniewicz, Jill S. Waibel, Jamie Weisman, Lindsay C. Strowd, Luna Sun, Yuxin Ding, Meghan Feely, Fabio P. Nunes, Eric L. Simpson> ;Dermatology and Therapy. 2021 Nov 30
• 6 citations
  Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis.
  Jonathan I. Silverberg, Eric L. Simpson, Mark Boguniewicz, Marjolein S. de Bruin-Weller, Peter Foley, Yoko Kataoka, Gaëlle Bégo-Le-Bagousse, Zhen Chen, Brad Shumel, Ji...> ;Acta Dermato-Venereologica. 2021 Nov 10
• 36 citations
  Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials.
  A. Wollenberg, Lisa A. Beck, M. de Bruin Weller, Eric L. Simpson, Shinichi Imafuku, Mark Boguniewicz, Rebecca Zachariae, Christina Olsen, Jacob P. Thyssen> ;The British Journal of Dermatology. 2021 Oct 12
• 11 citations
  Sleep Disturbances in Atopic Dermatitis in US Adults.
  Jonathan I. Silverberg, Zelma Chiesa-Fuxench, David J. Margolis, Mark Boguniewicz, Luz Fonacier, Mitchell H. Grayson, Eric L. Simpson, Peck Y. Ong> ;Dermatitis. 2021 Mar 5
• 27 citations
  Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis.
  Mark Boguniewicz, Lisa A. Beck, Lawrence Sher, Emma Guttman-Yassky, Diamant Thaçi, Andrew Blauvelt, Margitta Worm, Jonathan Corren, Weily Soong, Peter A. Lio, Ana B. R...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2021 Mar 1
• 14 citations
  Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial
  Elaine C. Siegfried, Thomas Bieber, Eric L. Simpson, Amy S. Paller, Lisa A. Beck, Mark Boguniewicz, Lynda C. Schneider, Faisal A. Khokhar, Zhen Chen, Randy Prescilla, ...> ;American Journal of Clinical Dermatology. 2021 Mar 1
• Join now to see all

Journal Articles

• Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families  
  Jonathan I Silverberg, Amy S Paller, Mark Boguniewicz, Sarah L Chamlin, Eric L Simpson, Lawrence F Eichenfield, Steven R Feldman, Dermatology and Therapy

Lectures

• Case Controversies in the Treatment of Atopic Dermatitis 
  American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019